Drug that reduces risk of developing Diabetes
September 17th, 2006
An International trial has found that a new drug called rosiglitazone can help reduce the risk of people developing Type II Diabetes.
Participants took rosiglitazone, known by the brand name Avandia, or a dummy placebo, while taking lifestyle advice. Over a period of three years, only 12 per cent of those taking rosiglitazone developed diabetes, compared with 26 per cent who became diabetic while taking the placebo. Rosiglitazone was also found to return glucose levels to normal in 51 per cent of participants versus 30 per cent of those taking a placebo. Read story
Other links of interest
Interactive Health Diabetes page
American Diabetes Association Home Page
Recent Comments